Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.37

+1.9%

11:40 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (22922)	7/8/1998 10:45:00 AM
From: Hippieslayer	Read Replies (6) of 32384

the thing that baffles me is if LGND has one of the best pipelines in the biz for a small biotech, why doesn't Wall st know this? Maybe because LGND is inept at promoting itself? My own personal take is that the street isn't interested in rewarding LGND on the nda of panretin is because it addresses a shrinking patient base that was already extremely small to begin with. As I have telegraphed before, I'm going to assume that Panretin has some nice off label usages that LGND is keeping quiet on. Other than that, Panretin just isn't an exciting blockbuster drug. Now, if Targetin pans out as the wonder drug as it has shown in rats (YEAH I LOVE RATS!!) and it works on diabetics, various cancers etc, then Wall st will have something to cheer about.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next